DCF Combined With Camrelizumab in the Treatment of Esophageal Cancer
Clinical trial NCT05050760 · UNKNOWN
Trial details
- NCT number
- NCT05050760
- Sponsor
- Xijing Hospital
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-01
- Primary completion
- 2023-12-01
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.